Exelon 13.3 mg patches (rivastigmine) work better than the lower-dose patches.

January 1

This is partially true...but don’t get too excited.

Increasing the dose from 9.5 mg to 13.3 mg doesn’t change the rate of cognitive decline. It MAY slightly improve some activities of daily living...but it’s questionable if the changes are even noticeable.

And more patients on the higher dose complain about side effects...nausea, vomiting, dizziness.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote